Povucite za promjenu položaja poklopca
The cycle 1b clinical trial in the CD40-activating antibody CP-870,893 in combination with cisplatin along with pemetrexed inside malignant pleural mesothelioma cancer.
- 0 postovi
- https://www.selleckchem.com/products/apr-246-prima
- Žena
Izrežite svoj avatar
